Clinical Trial Update: Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region.

View source ↗

Summary

The clinical trial is currently recruiting to evaluate quality of life and tolerance of vectorized internal radiotherapy (RIV) in patients with metastatic neuro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumor

Drugs mentioned

• Vectorized Internal Radiotherapy (RIV) (Vectorized Internal Radiotherapy)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Metastatic Neuroendocrine Tumour | Status: RECRUITING